Drug Metabolism and Disposition (DMD) is a monthly journal presenting the results of basic and clinical in vivo and in vitro research on the metabolism, transport, and disposition of small-molecule drugs, therapeutic proteins, and environmental chemicals. DMD’s topics include the metabolism and transport of endogenous compounds; mechanisms that affect expression and regulation of drug-metabolizing enzymes and transporters, including genetic variability; genetic, nutritional, or hormonal factors that influence the biological fate of chemicals; and the toxicologic consequences of xenobiotic metabolism.
For every issue, the table of contents (TOC) as well as the Future TOC and Fast Forward alerts (articles published ahead of an issue) are emailed to registered individuals. When you buy an email alert ad, your ad is placed in all of these alerts that are disseminated monthly and several times weekly. DMD receives over 720,000 hits per month.
Readers work in industry, government, and academic research, using a variety of approaches including cultured cells, heterologous expression systems, and mathematical modeling.
Advertising for Drug Metabolism and Disposition can be secured through FASEB AdNet, a network for advertisers and publishers in the life sciences, at www.faseb.org/AdNet. Link directly to find more information on:
- Current Advertising Rates
- Ad Types Available
- Advertising Policies and Conditions
- Other Opportunities with this Publisher
Contact FASEB AdNet:
9650 Rockville Pike, Bethesda, MD 20814-3998
Product and Recruitment Ad Sales: 800.43.FASEB ext. 7103 or 301.634.7103
Production: 800.43.FASEB ext. 7117 or 7791 or 301.634.7117 or 301-634-7791